Reversible Cryopreservation System for Donor Organs

About Until Labs

Until Labs is a well-funded, ambitious biotech startup tackling the profound challenge of reversible cryopreservation. Founded in 2020 and based in San Francisco, the company is initially focusing on creating a platform to preserve donor organs, which addresses a critical unmet need in transplantation while de-risking the science for more complex applications. With over $100 million in funding and a multidisciplinary team, Until is developing integrated workflows encompassing perfusion, cryoprotectants, and controlled cooling/rewarming to safely 'pause' and resume biological function.

Therapeutic Areas

Other Organ Preservation for Transplantation Drugs